相似文献
1
Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR.
Nat Rev Mol Cell Biol. 2012 Mar 14;13(4):213-24. doi: 10.1038/nrm3312.
2
Functions of Cholesterol Metabolites.
J Nutr Sci Vitaminol (Tokyo). 2015;61 Suppl:S151-3. doi: 10.3177/jnsv.61.S151.
3
Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism.
Postepy Hig Med Dosw (Online). 2007 Dec 3;61:736-59.
4
LXRS and FXR: the yin and yang of cholesterol and fat metabolism.
Annu Rev Physiol. 2006;68:159-91. doi: 10.1146/annurev.physiol.68.033104.152158.
5
Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home?
Circ Res. 2004 Oct 1;95(7):660-70. doi: 10.1161/01.RES.0000143422.83209.be.
6
Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis.
Biochem Pharmacol. 2009 Apr 15;77(8):1316-27. doi: 10.1016/j.bcp.2008.11.026. Epub 2008 Dec 3.
7
Nuclear receptors and cholesterol metabolism in the intestine.
Atheroscler Suppl. 2015 Feb;17:9-11. doi: 10.1016/S1567-5688(15)50003-2.
8
BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis.
J Lipid Res. 2002 Jan;43(1):2-12.
9
The emerging role of constitutive androstane receptor and its cross talk with liver X receptors and peroxisome proliferator-activated receptor A in lipid metabolism.
Vitam Horm. 2013;91:243-58. doi: 10.1016/B978-0-12-407766-9.00010-9.
10
Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
Obes Surg. 2019 Sep;29(9):2912-2922. doi: 10.1007/s11695-019-03918-0.
引用本文的文献
1
Tissue specific role of ABCA1 in lung cholesterol homeostasis under high-cholesterol diet.
Front Nutr. 2025 Jul 30;12:1649407. doi: 10.3389/fnut.2025.1649407. eCollection 2025.
2
Pediatric Familial Hypercholesterolemia: Targeting Intestinal Absorption and Other Therapeutic Strategies.
Nutrients. 2025 Jul 18;17(14):2357. doi: 10.3390/nu17142357.
3
Novel Approaches in Glucose and Lipid Metabolism Disorder Therapy: Targeting the Gut Microbiota-Bile Acid Axis.
Biology (Basel). 2025 Jul 2;14(7):802. doi: 10.3390/biology14070802.
4
Attenuation of chlorpyrifos-induced liver injury, oxidative stress and inflammation by selenium nanoparticles via SIRT1/FXR/Nrf2 signaling pathway modulation.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 23. doi: 10.1007/s00210-025-04465-5.
5
Adipose tissue-derived PRXL2A suppresses hepatic lipogenesis in a study with male mice.
Nat Commun. 2025 Jul 16;16(1):6567. doi: 10.1038/s41467-025-61963-z.
6
Gut microbiota's role in heart failure.
Heart Fail Rev. 2025 Jul 9. doi: 10.1007/s10741-025-10543-w.
7
The gut microbiota-bile acid axis: a crucial regulator of immune function and metabolic health.
World J Microbiol Biotechnol. 2025 Jun 25;41(7):215. doi: 10.1007/s11274-025-04395-7.
8
Role of Nuclear Receptors on the Progression of Multiple Sclerosis: A Review.
Cell Mol Neurobiol. 2025 Jun 17;45(1):58. doi: 10.1007/s10571-025-01563-z.
9
Intermittent fasting and metabolic dysfunction-associated steatotic liver disease: the potential role of the gut-liver axis.
Cell Biosci. 2025 May 23;15(1):64. doi: 10.1186/s13578-025-01406-w.
10
Ubiquitination in lipid metabolism reprogramming: implications for pediatric solid tumors.
Front Immunol. 2025 Apr 30;16:1554311. doi: 10.3389/fimmu.2025.1554311. eCollection 2025.
本文引用的文献
1
FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptors.
Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20107-12. doi: 10.1073/pnas.1111589108. Epub 2011 Nov 22.
2
ATP binding cassette transporter G1 (ABCG1) is an intracellular sterol transporter.
Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19719-24. doi: 10.1073/pnas.1113021108. Epub 2011 Nov 17.
3
The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor.
Genes Dev. 2011 Jun 15;25(12):1262-74. doi: 10.1101/gad.2056211.
4
Aldo-keto reductase 1B7 is a target gene of FXR and regulates lipid and glucose homeostasis.
J Lipid Res. 2011 Aug;52(8):1561-8. doi: 10.1194/jlr.M015859. Epub 2011 Jun 5.
5
FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway.
Cell Metab. 2011 Jun 8;13(6):729-38. doi: 10.1016/j.cmet.2011.03.019.
6
Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure.
J Biol Chem. 2011 Jul 29;286(30):26913-20. doi: 10.1074/jbc.M111.248203. Epub 2011 Jun 1.
7
Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity.
Diabetes. 2011 Jul;60(7):1861-71. doi: 10.2337/db11-0030. Epub 2011 May 18.
8
Liver X receptors regulate de novo lipogenesis in a tissue-specific manner in C57BL/6 female mice.
Am J Physiol Endocrinol Metab. 2011 Jul;301(1):E210-22. doi: 10.1152/ajpendo.00541.2010. Epub 2011 Apr 26.
9
FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis.
Science. 2011 Mar 25;331(6024):1621-4. doi: 10.1126/science.1198363.
10
Constitutive activation of LXR in macrophages regulates metabolic and inflammatory gene expression: identification of ARL7 as a direct target.
J Lipid Res. 2011 Mar;52(3):531-9. doi: 10.1194/jlr.M010686. Epub 2010 Dec 27.
Zotero 插件